Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115002264 | 11500226 | 4 | F | 20150413 | 20160808 | 20150914 | 20160819 | EXP | US-PFIZER INC-2015296959 | PFIZER | 8.00 | YR | M | Y | 27.00000 | KG | 20160819 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115002264 | 11500226 | 1 | PS | CRIZOTINIB | CRIZOTINIB | 1 | Oral | 165 MG/M2, BID ON DAYS 1-21 COURSE A | 202570 | 165 | MG/M**2 | CAPSULE | |||||||
| 115002264 | 11500226 | 2 | SS | HYDROCORTISONE ACETATE. | HYDROCORTISONE ACETATE | 1 | Intrathecal | 7.5-12MG IT ON DAY 1 (AGE BASED DOSING) PROPHASE | U | 8917 | |||||||||
| 115002264 | 11500226 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | Intrathecal | 15-24MG IT ON DAY 1 (AGE BASED DOSING) PROPHASE | U | 71868 | |||||||||
| 115002264 | 11500226 | 4 | SS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 150 MG/M2, OVER 1-30 MINUTES Q12 HOURS ON DAYS 4 AND 5 (TOTAL 4 DOSES) COURSE A | U | 71868 | 150 | MG/M**2 | |||||||
| 115002264 | 11500226 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intrathecal | 7.5-12MG IT ON DAY 1 (AGE BASED DOSING) PROPHASE | 3120 | MG | U | 11719 | |||||||
| 115002264 | 11500226 | 6 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Intravenous (not otherwise specified) | 3000 MG/M2, OVER 3 HOURS ON DAY 1 COURSE A | 3120 | MG | U | 11719 | 3000 | MG/M**2 | |||||
| 115002264 | 11500226 | 7 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 5 MG/M2, PO QD ON DAYS 1-2 /DAYS 3-5 PROPHASE | 50 | MG | U | 0 | 5 | MG/M**2 | |||||
| 115002264 | 11500226 | 8 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 5 MG/M2, PO BID ON DAYS 1-5 COURSE A | 50 | MG | U | 0 | 5 | MG/M**2 | |||||
| 115002264 | 11500226 | 9 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 800 MG/M2, OVER 60 MIN ON DAYS 1-5 COURSE A | 4150 | MG | U | 0 | 800 | MG/M**2 | |||||
| 115002264 | 11500226 | 10 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 100 MG/M2, OVER 2 HOURS ON DAYS 4 AND 5 COURSE A | U | 0 | 100 | MG/M**2 | |||||||
| 115002264 | 11500226 | 11 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 200 MG/M2, CYCLIC, PROPHASE, OVER 15-30 MINUTES ON DAY 1 AND 2 | U | 0 | 200 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115002264 | 11500226 | 1 | Anaplastic large cell lymphoma T- and null-cell types |
| 115002264 | 11500226 | 2 | Anaplastic large cell lymphoma T- and null-cell types |
| 115002264 | 11500226 | 3 | Anaplastic large cell lymphoma T- and null-cell types |
| 115002264 | 11500226 | 5 | Anaplastic large cell lymphoma T- and null-cell types |
| 115002264 | 11500226 | 7 | Anaplastic large cell lymphoma T- and null-cell types |
| 115002264 | 11500226 | 9 | Anaplastic large cell lymphoma T- and null-cell types |
| 115002264 | 11500226 | 10 | Anaplastic large cell lymphoma T- and null-cell types |
| 115002264 | 11500226 | 11 | Anaplastic large cell lymphoma T- and null-cell types |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115002264 | 11500226 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115002264 | 11500226 | Febrile neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115002264 | 11500226 | 1 | 20150328 | 20150413 | 0 | |
| 115002264 | 11500226 | 2 | 20150323 | 0 | ||
| 115002264 | 11500226 | 3 | 20150323 | 0 | ||
| 115002264 | 11500226 | 4 | 20150401 | 0 | ||
| 115002264 | 11500226 | 5 | 20150323 | 0 | ||
| 115002264 | 11500226 | 6 | 20150328 | 0 | ||
| 115002264 | 11500226 | 7 | 20150323 | 0 | ||
| 115002264 | 11500226 | 8 | 20150328 | 20150401 | 0 | |
| 115002264 | 11500226 | 9 | 20150328 | 20150401 | 0 | |
| 115002264 | 11500226 | 10 | 20150401 | 0 | ||
| 115002264 | 11500226 | 11 | 20150323 | 0 |